Propagation of oestrogen receptor-positive and oestrogen-responsive normal human breast cells in culture

Nature Communications

Volumn 6, Issue , 2015, Pages

  Fridriksdottir, Agla J ^a   Kim, Jiyoung ^a   Villadsen, René ^a   Klitgaard, Marie Christine ^a,b   Hopkinson, Branden M ^a   Petersen, Ole William ^a   Ronnov Jessen, Lone ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ADAPALENE; BIOLOGICAL MARKER; CYTOKERATIN 20; EPITHELIAL CELL ADHESION MOLECULE; ESTROGEN RECEPTOR; KS20.8 PROTEIN; LAMININ RECEPTOR; NERVE CELL ADHESION MOLECULE; PROTEIN BCL 2; SOMATOMEDIN BINDING PROTEIN 5; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR GATA 3; UNCLASSIFIED DRUG; ESTROGEN;

BIOASSAY; CANCER; CELLS AND CELL COMPONENTS; ESTROGENIC COMPOUND; HOMINID; INHIBITOR; MOLECULAR ANALYSIS; PROTEIN;

ARTICLE; BREAST EPITHELIUM CELL; BREAST REDUCTION; CELL GROWTH; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; BREAST; CELL CULTURE; CELL CULTURE TECHNIQUE; CELL PROLIFERATION; CYTOLOGY; EPITHELIUM CELL; EVALUATION STUDY; FEMALE; FLOW CYTOMETRY; METABOLISM; PROCEDURES;

BREAST; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELLS, CULTURED; EPITHELIAL CELLS; ESTROGENS; FEMALE; FLOW CYTOMETRY; HUMANS; RECEPTORS, ESTROGEN;

EID: 84946944989     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms9786     Document Type: Article

References (62)

1. Petersen, O. W. & Polyak, K. Stem cells in the human breast. Cold Spring Harb. Perspect. Biol. 2, 1-15 (2010).
2. Hammond, S. L., Ham, R. G. & Stampfer, M. R. Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract. Proc. Natl Acad. Sci. USA 81, 5435-5439 (1984).
3. Petersen, O. W. & van Deurs, B. Growth factor control of myoepithelial-cell differentiation in cultures of human mammary gland. Differentiation 39, 197-215 (1988).
4. Taylor-Papadimitriou, J. et al. Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation to in vivo phenotypes and influence of medium. J. Cell. Sci. 94, 403-413 (1989).
5. Petersen, O. W., Høyer, P. E. & van Deurs, B. Frequency and distribution of estrogen receptor-positive cells in normal, nonlactating human breast tissue. Cancer Res. 47, 5748-5751 (1987).
6. Rønnov-Jessen, L., Petersen, O. W. & Bissell, M. J. Cellular changes involved in conversion of normal to malignant breast: the importance of the stromal reaction. Physiol. Rev. 76, 69-125 (1996).
7. Kang, K.-S. et al. Expression of estrogen receptors in a normal human breast epithelial cell type with luminal and stem cell characteristics and its neoplastically transformed cell lines. Carcinogenesis 18, 251-257 (1997).
8. Graham, J. D. et al. DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast. Endocrinology 150, 3318-3326 (2009).
9. Tanos, T. et al. Progesterone/RANKL is a major regulatory axis in the human breast. Sci. Transl. Med. 5, 1-10 (2013).
10. Stampfer, M. R. & Bartley, J. C. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo(a)pyrene. Proc. Natl Acad. Sci. USA 82, 2394-2398 (1985).
11. Lundholt, B. K., Briand, P. & Lykkesfeldt, A. E. Growth inhibition and growth stimulation by estradiol of estrogen receptor transfected human breast epithelial cell lines involve different pathways. Breast Cancer Res. Treat. 67, 199-214 (2001).
12. Zajchowski, D. A., Sager, R. & Webster, L. Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor. Cancer Res. 53, 5004-5011 (1993).
13. Denk, H., Lackinger, E., Zatloukal, K. & Franke, W. W. Turnover of cytokeratin polypeptides in mouse hepatocyes. Exp. Cell Res. 173, 137-143 (1987).
14. Moll, R., Löwe, A., Laufer, J. & Franke, W. W. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am. J. Pathol. 140, 427-447 (1992).
15. Clarke, R. B., Howell, A., Potten, C. S. & Anderson, E. Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res. 57, 4987-4991 (1997).
16. Asselin-Labat, M. L. et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat. Cell Biol. 9, 201-209 (2007).
17. Lu, J. et al. β-Galactoside α2,6 sialyltransferase 1 promotes transforming growth factor-β-mediated epithelial-mesenchymal transition. J. Biol. Chem. 289, 34627-34641 (2014).
18. Wheelock, M. J., Shintani, Y., Maeda, M., Fukumoto, Y. & Johnson, K. R. Cadherin switching. J. Cell Sci. 121, 727-735 (2008).
19. Levin, T. G. et al. Characterization of the intestinal cancer stem cell marker CD166 in the human and mouse gastrointestinal tract. Gastroenterology 139, 2072-2082 (2010).
20. Selleri, C. et al. The metastasis-associated 67-kDa laminin receptor is involved in G-CSF-induced hematopoietic stem cell mobilization. Blood 108, 2476-2484 (2006).
21. Westbury, C. B. et al. Genome-wide transcriptomic profiling of microdissected human breast tissue reveals differential expression of KIT (c-Kit, CD117) and oestrogen receptor-alpha (ERalpha) in response to therapeutic radiation. J. Pathol. 219, 131-140 (2009).
22. Villadsen, R. et al. Evidence of a stem cell hierarchy in the adult human breast. J. Cell Biol. 177, 87-101 (2007).
23. Rio, M. C. & Chambon, P. The pS2 gene, mRNA, and protein: a potential marker for human breast cancer. Cancer Cells 2, 269-274 (1990).
24. Ghosh, M. G., Thompson, D. A. & Weigel, R. J. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. Cancer Res. 60, 6367-6375 (2000).
25. Rønnov-Jessen, L. & Petersen, O. W. Induction of α-smooth muscle actin by transforming growth factor-β1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab. Invest. 68, 696-707 (1993).
26. Liu, X. et al. ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells. Am. J. Pathol. 180, 599-607 (2012).
27. Tan, D. W. M. et al. Single-cell gene expression profiling reveals funcional heterogeneity of undifferentiated human epidermal cells. Development 140, 1433-1444 (2013).
28. Garbe, J. C. et al. Molecular distinctions between stasis and telomere attrition senescence barriers shown by long-term culture of normal human mammary epithelial cells. Cancer Res. 69, 7557-7568 (2009).
29. Ewan, K. B. R. et al. Proliferation of estrogen receptor-α-positive mammary epithelial cells is restrained by transforming growth factor-β1 in adult mice. Am. J. Pathol. 167, 409-417 (2005).
30. Choudhury, S. et al. Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics. Cell Stem Cell 13, 117-130 (2013).
31. Bogina, G. et al. Comparison of anti-estrogen receptor antibodies SP1, 6F11, and 1D5 in breast cancer: lower 1D5 sensitivity but questionable clinical implications. Am. J. Clin. Pathol. 138, 697-702 (2012).
32. Augello, M. A., Hickey, T. E. & Knudsen, K. E. FOXA1: master of steroid receptor function in cancer. EMBO J. 30, 3885-3894 (2011).
33. Oakes, S. R., Hilton, H. N. & Ormandy, C. J. The alveolar switch: coordinating the proliferative cues and cell fate decisions that drive the formation of lobuloalveoli from ductal epithelium. Breast Cancer Res. 8, 207-216 (2006).
34. McGuire, Jr W. L. et al. Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action. J. Natl Cancer Inst. 84, 1336-1341 (1992).
35. Lim, E. et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat. Med. 15, 907-915 (2009).
36. Kato, S. et al. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270, 1491-1494 (1995).
37. Haslam, S. Z. Mammary fibroblast influence on normal mouse mammary epithelial cell responses to estrogen in vitro. Cancer Res. 46, 310-316 (1986).
38. Duss, S. et al. An ostrogen-dependent model of breast cancer created by transformation of normal mammary epithelial cells. Breast Cancer Res. 9, R38 (2007).
39. Shehata, M. et al. Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland. Breast Cancer Res. 14, R134 (2012).
40. Visvader, J. E. & Stingl, J. Mammary stem cells and the differentiation hierarchy: current status and perspective. Genes Dev. 28, 1143-1158 (2014).
41. Honeth, G. et al. Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium. Breast Cancer Res. 16, R52 (2014).
42. Arendt, L. M. et al. Human breast progenitor cell numbers are regulated by WNT and TBX3. PLoS ONE 9, 1-14 (2014).
43. Gupta, P. B. et al. Stochastic state transitions give rise to phenotypic equlibrium in populations of cancer cells. Cell 146, 633-644 (2011).
44. Shoker, B. S. et al. Estrogen receptor-positive proliferating cells in the normal and precancerous breast. Am. J. Pathol. 155, 1811-1815 (1999).
45. Moses, H. & Barcellos-Hoff, M. H. TGF-β biology in mammary development and breast cancer. Cold Spring Harb. Perspect. Biol. 3, a003277 (2011).
46. Hansen, A. G. et al. ALCAM/CD166 is a TGF-β-responsive marker and functional regulator of prostate cancer metastasis to bone. Cancer Res. 74, 1404-1415 (2014).
47. Cuzick, J. et al. Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data. Lancet 381, 1827-1834 (2013).
48. de Assis, S. et al. High-fat or ethinyl-oestradiol intake during pregnancy increases mammary cancer risk in several generations of offspring. Nat. Commun. 3, 1053-1061 (2012).
49. Cowper-Sal-lari, R. et al. Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression. Nat. Genet. 44, 1191-1200 (2012).
50. Laping, N. J. et al. Inhibition of transforming growth factor (TGF)-β1-induced extracellular matrix with a novel inhibitor of TGF-β1 type I receptor kinase activity: SB-431542. Mol. Pharmacol. 62, 58-64 (2002).
51. Gellibert, F. et al. Identification of 1,5-naphthyridine derivatives as a novel series of potent and selective TGF-β type I receptor inhibitors. J. Med. Chem. 47, 4494-4506 (2004).
52. Ichida, J. K. et al. A small-molecule inhibitor of TGF-β signaling replaces Sox2 in reprogramming by inducing Nanog. Cell Stem Cell 5, 491-503 (2009).
53. Ince, T. A. et al. Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes. Cancer Cell 12, 160-170 (2007).
54. Soule, H. D. et al. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50, 6075-6086 (1990).
55. Briand, P., Petersen, O. W. & van Deurs, B. A new diploid nontumorigenic human breast epithelial cell line isolated and propagated in chemically defined medium. In Vitro Cell. Dev. Biol. 23, 181-188 (1987).
56. Pasic, L. et al. Sustained activation of the HER1-ERK1/2-RSK signaling pathway controls myoepithelial cell fate in human mammary tissue. Genes Dev. 25, 1641-1653 (2011).
57. Kiyono, T. et al. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396, 84-88 (1998).
58. Counter, C. M. et al. Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc. Natl Acad. Sci. USA 95, 14723-14728 (1998).
59. Hines, W. C., Yaswen, P. & Bissell, M. J. Modelling breast cancer requires identification and correction of a critical cell lineage-dependent transduction bias. Nat. Commun. 6, 6927-6937 (2015).
60. Dvinge, H. & Bertone, P. HTqPCR: high-throughput analysis and visualization of quantitative real-time PCR data in R. Bioinformatics 25, 3325-3326 (2009).
61. -ΔΔCt method. Methods 25, 402-408 (2001).
62. Rønnov-Jessen, L., Celis, J. E., van Deurs, B. & Petersen, O. W. A fibroblast-associated antigen: characterization in fibroblasts and immunoreactivity in smooth muscle differentiated stromal cells. J. Histochem. Cytochem. 40, 475-486 (1992).